Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Applied Industrial Technologies enters its October 27 earnings report with the stock up 6% over the past month, analysts firmly on the bull side, and short sellers posing little structural threat. The interesting question heading into the print is not whether shorts are a risk, but whether the stock can close the gap to analyst targets after a post-results re-rating that already lifted the Street by a wide margin.
The positioning picture is almost entirely one-sided in AIT's favour. Short interest is just 2.4% of the free float, and it has barely moved this week, down about 0.4%. The borrow market is deeply relaxed. The cost to borrow dropped sharply to 0.13%, roughly a third of where it stood just one week ago, and availability is at roughly 6,900% of short interest, meaning shares to borrow outnumber borrowed shares by a factor of nearly 70. There is no squeeze pressure here, and the short score of 33 sits comfortably in the middle of the range. Options traders have turned less defensive than usual, with the put/call ratio at 1.83 versus a 20-day average of 2.01. The ratio is close to a full standard deviation below that average, suggesting some unwinding of the defensive positioning that had characterised recent weeks. Taken together, the lending market and options market both tell the same story: the bears have largely stood aside.
The Street's conviction on AIT is broad and, notably, recent. Following the August 13 earnings print, five firms raised price targets on the same day, with targets landing in a range of $390 to $420. B of A Securities maintained its Buy rating and lifted to $390. Keybanc set the high-water mark at $420, holding its Overweight. Baird moved the most aggressively in absolute terms, raising from $317 to $400. The consensus target of $359.50 now sits modestly above the current price of $344.99, implying roughly 4% upside, which means the stock has effectively caught up with much of the post-earnings re-rating. The bull case rests on FY27 guidance of $11.65 to $12.15 EPS alongside 4% to 6.5% sales growth, nearly $2 billion in acquisition capacity, and a net leverage ratio of just 0.22x. Bears counter that gross margins remain under pressure from LIFO accounting and tariff pass-through risk, and that the business is inherently cyclical in North American industrial capex. The PE of 26.6x and EV/EBITDA of 18.9x are not demanding for the quality on offer, but the EV/EBIT factor rank of 33 out of 100 shows the stock is not cheap in that frame.
Institutional ownership tells a supportive story. BlackRock holds 10.8% of shares and added roughly 115,000 shares as recently as September 30. State Street, Capital Research, and First Trust all added incrementally in the same period. AQR took a larger position over the June quarter, adding 423,000 shares, while Fuller and Thaler added 331,000. The main name trimming is Alyeska, which cut its stake by about 100,000 shares. No 13D activist is on the register. The largest 13G filer is BlackRock, reporting 8.6% as of July 2025 and now holding a materially larger stake per the institutional data. All 13D/G stakes are as last disclosed around the 5% threshold and holders dropping below that level can exit without a further filing.
Retail attention has picked up sharply. Wikipedia pageview data tracked by ORTEX shows a z-score of 2.46 against the company's own 90-day history as of late September. That is meaningfully above normal, though this is an attention signal rather than a financial lead.
On the insider side, the most relevant open-market transactions are a director sale of 1,904 shares at $340.45 in late August and a CFO sale of 1,812 shares at $355.10 around the same time. Net insider activity over 90 days is negative by about 3,700 shares and roughly $1.3 million in value. The CFO sale was not under a 10b5-1 plan. Neither transaction is large enough to be alarming at these price levels, but the absence of open-market buying by senior management ahead of an earnings date is worth noting.
Peer performance this week has been broadly positive. WCC rose 5.2%, MSM gained 4.6%, and SUNB added 6.4%. CTOS led the group with an 8% gain. AIT's own 2.6% weekly gain is in line with the group but not at the top. The question heading into October 27 is whether the guidance range management issued for FY27 holds up as the data on North American industrial demand continues to come in.
See the live data behind this article on ORTEX.
Open AIT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
